Mereo BioPharma Group plc Annual Depreciation in USD from 2022 to 2023

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: Mereo BioPharma Group plc quarterly/annual Depreciation history and growth rate from 2022 to 2023.
Mereo BioPharma Group plc Depreciation for the quarter ending June 30, 2024 was $100K, unchanged year-over-year.
Mereo BioPharma Group plc annual Depreciation for 2023 was $171K, a 5.53% decline from 2022.

Depreciation, Annual (USD)

Depreciation, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$171K	-$10K	-5.53%	Jan 1, 2023	Dec 31, 2023	10-K	2024-03-27
2022	$181K			Jan 1, 2022	Dec 31, 2022	10-K	2024-03-27

* An asterisk sign (*) next to the value indicates that the value is likely invalid.